|Articles|March 18, 2021
Automated Method Development of Oligonucleotide in Tissues Using Clarity OTX 96-Well Plate and High-Resolution Mass Spectrometry
Author(s)Phenomenex, Inc.
As synthetic oligonucleotide therapeutics traverse the drug-development path, there is an increasing need for TK and PK/PD studies in drug discovery and development.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Quantitative LC–MS/MS Method Refines rAAV9 Capsid Protein Stoichiometry
2
LCGC Blog: Updates from the ACS SCSC for the Separation Science Community
3
Advancing Affinity Supports Through Innovative Immobilization Strategies
4
Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics
5
